New program would require contracted drug makers to keep a 6-month supply of critical medicines.
This bill would create a new program to help prevent drug shortages and prepare for public health emergencies. It would offer contracts to drug manufacturers, requiring them to keep a 6-month reserve of critical medicines and their ingredients. This aims to ensure that patients and the healthcare system have access to necessary drugs when supply chains are vulnerable.
Today, there is no federal program that specifically requires drug manufacturers to keep a rolling reserve of critical drug ingredients and finished medicines to prevent shortages. This bill would create such a program, requiring companies that receive federal contracts to maintain a regularly replenished 6-month reserve of these critical supplies. It would also allow the Secretary to help fund the building or renovation of non-government-owned facilities for emergency preparedness or drug production. The bill would allow for $500,000,000 to be set aside in the government's budget year 2026 to fund this effort.
HR 3955 · 119th Congress · June 12, 2025 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
6 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.